Risk of Hepatocellular Carcinoma with Glucagon-like Peptide-1 receptor agonist treatment in patients: a systematic review and meta-analysis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Risk of Hepatocellular Carcinoma with Glucagon-like Peptide-1 receptor agonist treatment in patients: a systematic review and meta-analysis ; volume:24 ; number:1 ; day:18 ; month:11 ; year:2024 ; pages:1-11 ; date:12.2024
BMC endocrine disorders ; 24, Heft 1 (18.11.2024), 1-11, 12.2024
- Urheber
-
Shabil, Muhammed
Khatib, Mahalaqua Nazli
Ballal, Suhas
Bansal, Pooja
Tomar, Balvir S.
Ashraf, Ayash
Kumar, M. Ravi
Sinha, Aashna
Rawat, Pramod
Gaidhane, Abhay M.
Sah, Sanjit
Daniel, Afukonyo Shidoiku
Yappalparvi, Ambanna
Bushi, Ganesh
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12902-024-01775-2
- URN
-
urn:nbn:de:101:1-2502042059508.024949646596
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:23 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Shabil, Muhammed
- Khatib, Mahalaqua Nazli
- Ballal, Suhas
- Bansal, Pooja
- Tomar, Balvir S.
- Ashraf, Ayash
- Kumar, M. Ravi
- Sinha, Aashna
- Rawat, Pramod
- Gaidhane, Abhay M.
- Sah, Sanjit
- Daniel, Afukonyo Shidoiku
- Yappalparvi, Ambanna
- Bushi, Ganesh
- SpringerLink (Online service)
Ähnliche Objekte (12)
Glucagon-like peptide-1 and glucagon-like peptide-2 regulation during human liver regeneration
Glucagon-like peptide 1 (GLP-1)
Glucagon-like peptide-1 7-36 amid
Experiences with Glucagon-Like Peptide-1 Receptor Agonist in Children with Acquired Hypothalamic Obesity
„Glucagon-like peptide‑1“(GLP‑1)-Rezeptor-Agonisten – die neuen Wunderwaffen in der Adipositastherapie?
Glucagon-Like Peptide-1 Receptor Agonist Cases Reported to United States Poison Centers, 2017–2022
Glucagon-like peptide-1-Immunoreaktivität in gastropankreatischen endokrinen Tumoren
Untersuchungen zur Struktur-Wirkungsbeziehung von Glucagon-like peptide-1
Glucagon-like peptide-1 receptor agonist, liraglutide, attenuated retinal thickening in spontaneously diabetic Torii fatty rats
The glucagon-like peptide-1 receptor agonist exendin-4 ameliorates warfarin-associated hemorrhagic transformation after cerebral ischemia
The insulinotropic gut hormone glucagon-like peptide-1 : 20 tables
Untersuchungen zur Struktur-Wirkungsbeziehung des Inkretinhormons Glucagon-like Peptide-1
Glucagon-like peptide-1 and glucagon-like peptide-2 regulation during human liver regeneration
Glucagon-like peptide 1 (GLP-1)
Glucagon-like peptide-1 7-36 amid
Experiences with Glucagon-Like Peptide-1 Receptor Agonist in Children with Acquired Hypothalamic Obesity
„Glucagon-like peptide‑1“(GLP‑1)-Rezeptor-Agonisten – die neuen Wunderwaffen in der Adipositastherapie?
Glucagon-Like Peptide-1 Receptor Agonist Cases Reported to United States Poison Centers, 2017–2022
Glucagon-like peptide-1-Immunoreaktivität in gastropankreatischen endokrinen Tumoren
Untersuchungen zur Struktur-Wirkungsbeziehung von Glucagon-like peptide-1
Glucagon-like peptide-1 receptor agonist, liraglutide, attenuated retinal thickening in spontaneously diabetic Torii fatty rats
The glucagon-like peptide-1 receptor agonist exendin-4 ameliorates warfarin-associated hemorrhagic transformation after cerebral ischemia
The insulinotropic gut hormone glucagon-like peptide-1 : 20 tables
Untersuchungen zur Struktur-Wirkungsbeziehung des Inkretinhormons Glucagon-like Peptide-1
Glucagon-like peptide-1 and glucagon-like peptide-2 regulation during human liver regeneration
Glucagon-like peptide 1 (GLP-1)
Glucagon-like peptide-1 7-36 amid
Experiences with Glucagon-Like Peptide-1 Receptor Agonist in Children with Acquired Hypothalamic Obesity
„Glucagon-like peptide‑1“(GLP‑1)-Rezeptor-Agonisten – die neuen Wunderwaffen in der Adipositastherapie?
Glucagon-Like Peptide-1 Receptor Agonist Cases Reported to United States Poison Centers, 2017–2022
Glucagon-like peptide-1-Immunoreaktivität in gastropankreatischen endokrinen Tumoren
Untersuchungen zur Struktur-Wirkungsbeziehung von Glucagon-like peptide-1
Glucagon-like peptide-1 receptor agonist, liraglutide, attenuated retinal thickening in spontaneously diabetic Torii fatty rats
The glucagon-like peptide-1 receptor agonist exendin-4 ameliorates warfarin-associated hemorrhagic transformation after cerebral ischemia
The insulinotropic gut hormone glucagon-like peptide-1 : 20 tables